• A Taxonomy of Generative Artificial Intelligence in Health Economics and Outcomes Research: An ISPOR Working Group Report

    Nov 1, 2025, 00:00

  • Validating Loon Lens 1.0 for Autonomous Abstract Screening and Confidence-Guided Human-in-the-Loop Workflows in Systematic Reviews

    Nov 1, 2025, 00:00

  • Table of Contents

    Nov 1, 2025, 00:00

  • Who Needs Real Data Anyway? Exploring the Use of Synthetic Data in Economic Evaluations of Health Interventions

    Nov 1, 2025, 00:00

  • Artificial Intelligence in Health Economics and Outcomes Research: Highlighting the Contributions of Early Career Researchers

    Nov 1, 2025, 00:00

  • Roles of Artificial Intelligence--Based Synthetic Data in Health Economics and Outcomes Research

    Nov 1, 2025, 00:00

  • ELEVATE-GenAI: Reporting Guidelines for the Use of Large Language Models in Health Economics and Outcomes Research: An ISPOR Working Group Report

    Nov 1, 2025, 00:00

  • Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Trial-Based Economic Evaluation

    Nov 1, 2025, 00:00

  • The “Artificial Intelligence Statistician”: Utilizing Generative Artificial Intelligence to Select an Appropriate Model and Execute Network Meta-Analyses

    Nov 1, 2025, 00:00

  • Meditation and Mindfulness Practices as Supporting Tools to Mental Health Interventions in the Philippines

    Nov 1, 2025, 00:00

  • Strong Preferences or Simplifying Heuristics? Using Internal Validity Tests and Latent Class Analysis to Better Understand Stated Preference Survey Results. A Case Example in Health Preferences Research

    Nov 1, 2025, 00:00

  • Use of Large Language Models to Extract Cost-Effectiveness Analysis Data: A Case Study

    Nov 1, 2025, 00:00

  • Author Reply

    Nov 1, 2025, 00:00

  • An Assessment of the Maturity of Cancer Survival Data Used in Economic Models for the National Institute for Health and Care Excellence’s Single Technology Appraisals

    Nov 1, 2025, 00:00

  • Role of Generative Artificial Intelligence in Assisting Systematic Review Process in Health Research: A Systematic Review

    Nov 1, 2025, 00:00

  • Unravelling Public Preferences for the Use of Artificial Intelligence Mobile Health Applications in Australia

    Nov 1, 2025, 00:00

  • Generative Artificial Intelligence to Automate the Adaptation of Excel Health Economic Models and Word Technical Reports

    Nov 1, 2025, 00:00

  • Are Generic Preference-Based Measures Valid for Use in Informal Carers? A Psychometric Investigation

    Nov 1, 2025, 00:00

  • Development and Use of Cognition Bolt-Ons for the EQ-5D-3L and EQ-5D-5L: A Systematic Review

    Nov 1, 2025, 00:00

  • Reevaluating Artificial Intelligence–Enabled Emergency Care in the National Health Service:  Economic Value, Diagnostic Realities, and Ethical Challenges

    Nov 1, 2025, 00:00

  • Health Economics and Outcomes Research in the New Era of Artificial Intelligence: Catch Me If You Can

    Nov 1, 2025, 00:00

  • A4SLR: An Agentic Artificial Intelligence-Assisted Systematic Literature Review Framework to Augment Evidence Synthesis for Health Economics and Outcomes Research and Health Technology Assessment

    Nov 1, 2025, 00:00

  • How Similar Is Similar Enough? Assessment of Indirect Treatment Comparisons to Support Similarity for National Institute for Health and Care Excellence’s Cost Comparison Route

    Nov 1, 2025, 00:00

  • Author Reply

    Nov 1, 2025, 00:00

  • Editorial Board

    Oct 29, 2025, 10:30

  • Editorial Board

    Oct 6, 2025, 12:01

  • Assessing the Health-Related Quality of Life of Children With Asthma or Eczema by a Proxy: Does Assessment Perspective Matter?

    Oct 6, 2025, 08:52

  • Economic Evaluations of Treatment of Depressive Disorders in Adolescents: A Scoping Review

    Oct 1, 2025, 00:00

  • Rare Disease Policy in High-Income Countries: An Overview of Achievements, Challenges, and Solutions

    Oct 1, 2025, 00:00

  • Cost-Effectiveness of Long-Chain Omega-3 Supplementation for the Secondary Prevention of Cardiovascular Disease in the United States

    Oct 1, 2025, 00:00

  • Head-to-Head Comparisons of the Distributional Characteristics and Measurement Properties of the 3-Level and 5-Level Versions of the EQ-5D-Y: A Systematic Review

    Oct 1, 2025, 00:00

  • Development of the County-Level Social Deprivation Index 2020 and Its Association With Health Outcomes in China

    Oct 1, 2025, 00:00

  • Construction and Validation of a Risk Prediction Model for Prolonged Hospitalization of Very Premature Infants

    Oct 1, 2025, 00:00

  • Extending Multidimensional Thresholding to Include Categorical Attributes

    Oct 1, 2025, 00:00

  • Estimated True Out-of-Pocket Cost Changes From the Inflation Reduction Act on Medicare Part D Beneficiaries With Cancer

    Oct 1, 2025, 00:00

  • Provider Differences in Costs, Utilization, and Quality of Primary Care for Traumatic Brain Injury in the Military

    Oct 1, 2025, 00:00

  • Measuring Aversion to Income-Related Health Inequality in Canada: An Equity-Efficiency Trade-Off Experiment

    Oct 1, 2025, 00:00

  • Cost per Opioid-Free Year: A Systematic Review and Summary Analysis

    Oct 1, 2025, 00:00

  • Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare

    Oct 1, 2025, 00:00

  • Meaningful Score Differences and Meaningful Score Regions of the Patient-Reported Outcomes Measurement Information System® Pediatric Asthma Impact Scale

    Oct 1, 2025, 00:00

  • Distributional Cost-Effectiveness Analysis and Health Technology Assessment at NICE

    Oct 1, 2025, 00:00

  • Table of Contents

    Oct 1, 2025, 00:00

  • Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics

    Oct 1, 2025, 00:00

  • Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel

    Oct 1, 2025, 00:00

  • Using Machine Learning to Match Clients and Therapy Providers: Evaluating Clinical Quality and Cost of Care

    Sep 1, 2025, 00:00

  • Comparisons of Preferences Toward EQ-5D-Y-3L Health States Between Adult Own and Child Perspectives

    Sep 1, 2025, 00:00

  • Utility Studies in Rare Diseases: A Systematic Literature Review

    Sep 1, 2025, 00:00

  • Quality of Care for Patients With Advanced Illness Scale: Development, Preference Elicitation, and Evaluation of Measurement Properties

    Sep 1, 2025, 00:00

  • Validity and Reliability of the EQ-HWB in Parents of Children With Health Conditions

    Sep 1, 2025, 00:00

  • Author Reply

    Sep 1, 2025, 00:00

  • Building Blocks of Value Creation Within Value-Based Health Systems: A Delphi Study

    Sep 1, 2025, 00:00

  • Validity of the EQ-5D-5L for Routine Assessment in Residential Aged Care: Results From a Feasibility Study

    Sep 1, 2025, 00:00

  • Referencing Drug Prices of Other Countries May Not Sustainably Lower Prices in the United States: Lessons From Europe

    Sep 1, 2025, 00:00

  • Stability of Danish Population Health Preferences Over Time

    Sep 1, 2025, 00:00

  • Addressing Limitations in the Cost-Effectiveness Analysis of Digitally Supported Care Management for Dementia Caregivers

    Sep 1, 2025, 00:00

  • Value-Based Care: Lessons for the United Kingdom’s National Health Service

    Sep 1, 2025, 00:00

  • Do We Always Need a New Preference Study? A Scoping Review of Promising Research Areas for Meta-Analyses and Benefit Transfers of Patient Preference Studies

    Sep 1, 2025, 00:00

  • Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort Study

    Sep 1, 2025, 00:00

  • Optimizing Monte Carlo Sampling in Health-Economic Modeling: Underlying Concepts and Parameter Definitions

    Sep 1, 2025, 00:00

  • Author Reply

    Sep 1, 2025, 00:00

  • The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The Netherlands

    Sep 1, 2025, 00:00

  • Health State Utilities for Achondroplasia: A Time Trade-Off Study

    Sep 1, 2025, 00:00

  • Table of Contents

    Sep 1, 2025, 00:00

  • Is There a General Preference for the Worse Off? A Discrete Choice Experiment Using Individually Calibrated Health State Valuations

    Sep 1, 2025, 00:00

  • Editorial Board

    Aug 26, 2025, 09:11

  • Growing Evidence Base on Condition-Specific Patient-Reported Outcome Measures for Long COVID

    Aug 1, 2025, 00:00

  • Table of Contents

    Aug 1, 2025, 00:00

  • A Comparative Study of Health and Well-Being Measures in Ireland Using EQ Health and Wellbeing (EQ-HWB) and its Short Version, EQ-5D-5L, and ICEpop Capability Measure for Adults (ICECAP-A)

    Aug 1, 2025, 00:00

  • Understanding the Transition Between Age-Specific Measures of Health-Related Quality of Life: Evidence on the Relationship Between and Comparative Performance of the EQ-5D-Y-5L and EQ-5D-5L

    Aug 1, 2025, 00:00

  • Exemption System for Economic Evaluation Data Submission for Pharmaceuticals in South Korea: Achievements and Challenges

    Aug 1, 2025, 00:00

  • A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review

    Aug 1, 2025, 00:00

  • Costs and Outcomes After Primary and Revision Hip Replacements by Implant Bearing Materials: Analysis of 550 760 linked Patient Records from English Routinely Collected Databases

    Aug 1, 2025, 00:00

  • Early Budget Impact Analysis of Artificial Intelligence to Support the Review of Radiographic Examinations for Suspected Fractures in National Health Service Emergency Departments

    Aug 1, 2025, 00:00

  • Mapping EQ-5D-5L Utilities in Dementia: Integrating Self and Proxy Reports

    Aug 1, 2025, 00:00

  • The Increasing Use of Clinical Outcome Assessments in US Food and Drug Administration Labels and the German Gemeinsamer Bundesausschuss, National Institute for Health and Care Excellence, and the French Haute Autorité de Santé Assessments F ...

    Aug 1, 2025, 00:00

  • The Psychometric Performance of the EQ Health and Wellbeing in Caregivers of Persons Living With Dementia

    Aug 1, 2025, 00:00

  • Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity

    Aug 1, 2025, 00:00

  • The Burden of Mitochondrial Disease: Healthcare and Societal Costs

    Aug 1, 2025, 00:00

  • Implementing the Generalized Risk-Adjusted Cost-Effectiveness Model for Sickle Cell Disease: A Case Study

    Aug 1, 2025, 00:00

  • The Value of Hope in Cancer Care: Risk Preference and Heterogeneity in Cancer Patients and the General Public

    Aug 1, 2025, 00:00

  • Realizing the Economic Potential of Meditation and Mindfulness Practices in Mental Health Care

    Aug 1, 2025, 00:00

  • Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-Centered Decision Making in Healthcare

    Aug 1, 2025, 00:00

  • Psychometric Properties of the Modified EQ Health and Wellbeing and its Shorter Version in a General Chinese Population: A Comparative Analysis With EQ-5D-5L, SF-6Dv2, ICEpop CAPability measure for Adults, Short Version of Warwick-Edinburgh ...

    Aug 1, 2025, 00:00

  • The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set

    Aug 1, 2025, 00:00

  • An Exploratory Study of Alternative Time Frames and Descriptors for EQ-5D-5L in Obstructive Airway Diseases Using Mixed Methods

    Aug 1, 2025, 00:00

  • A Systematic Review and Meta-Analysis of Health-State Utility Values for Infectious Diseases With Pandemic Potential and Associated Vaccine Adverse Reactions

    Aug 1, 2025, 00:00

  • Addressing Subgroup-Specific Treatment Effects to Avoid Inefficient Care: The Conflict Between Statistical and Health Economic Analyses

    Aug 1, 2025, 00:00

  • Editorial Board

    Jul 31, 2025, 08:55

  • SA17 Assessing the Impact of Frailty on Healthcare Burden Post-Surgery in Head and Neck Cancer Patients

    Jul 14, 2025, 17:02

  • Editorial Board

    Jul 3, 2025, 09:29

  • HPR152 Characterizing Social Determinants of Health in the Population Receiving Respiratory Syncytial Virus Vaccination in a Nationwide Pharmacy Chain in the United States

    Jul 1, 2025, 00:00

  • HPR137 HTA Assessments for Multipurpose Contrast Agents: Insights and Solutions to Formal HTA Challenges

    Jul 1, 2025, 00:00

  • CO57 Comparative Clinical Effectiveness of Analgesics for the Treatment of Moderate-to-Severe Acute Pain: A Systematic Review and Network Meta-Analysis

    Jul 1, 2025, 00:00

  • EE490 Novel Value Elements: Developing and Applying a Pragmatic Framework in Early Stages of Product Development

    Jul 1, 2025, 00:00

  • EE312 Absenteeism and Presenteeism Associated With Chronic Conditions in a Canadian Working Population

    Jul 1, 2025, 00:00

  • P31 Using Z Codes to Characterize Health and Social Histories in Commercially Insured Non-Hodgkin Lymphoma Patients: Insights from Real-World Data

    Jul 1, 2025, 00:00

  • EE245 Continuous Avoidance Cost in Biosimilar: A Budget Impact Analysis on the Basis of Clinical Trial Model and RWD in Brazil / LATAM / LMIC

    Jul 1, 2025, 00:00

  • P36 Comparative Analysis of Large Language Models for Extracting Patient-Reported Outcome Measures From Clinical Trial Protocols in Lymphoma

    Jul 1, 2025, 00:00

  • PCR145 Health-Related Quality of Life and Productivity Losses Across Stages of Breast and Colorectal Cancer

    Jul 1, 2025, 00:00

  • HPR3 Determinants of Clinical Trial Participation in Prostate Cancer Patients: A Nationwide Medicare Analysis

    Jul 1, 2025, 00:00

  • PCR146 Using Machine Learning to Identify Key Predictors of Health-Related Quality of Life in Older Women with Early-Stage Breast Cancer Undergoing Endocrine Therapy

    Jul 1, 2025, 00:00

  • PCR35 Health Utilities Associated With Pneumococcal Diseases in Children and Adults in the United States: A Targeted Literature Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • Mapping the Kidney Disease Quality-of-Life Questionnaire Onto the EQ-5D-5L Utility Index in Patients Undergoing Hemodialysis

    Jul 1, 2025, 00:00

  • MSR48 Discrete-Event Simulation Model Projects Economic Outcomes Associated with Long-Term Clinical Remission in Patients with Severe Asthma Receiving Mepolizumab

    Jul 1, 2025, 00:00

  • MSR87 Using Regression Discontinuity in Time Design for Real-World Comparative Effectiveness: A Case Study for the Second-Line Use of Pembrolizumab in Advanced Non-Small Cell Lung Cancer

    Jul 1, 2025, 00:00

  • HSD34 Telehealth for Disease Management: A Scoping Review of Effectiveness in the Perinatal Period

    Jul 1, 2025, 00:00

  • PCR221 Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality of Life (HRQoL) Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Jul 1, 2025, 00:00

  • RWD27 COVID Impact on Cardiac Implantable Eletronic Devices Trends in the Brazilian Public Health System: a Joinpoint Regression Analysis

    Jul 1, 2025, 00:00

  • RWD114 Real-World Characteristics and Treatment Patterns With Nintedanib in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective US Claims Study

    Jul 1, 2025, 00:00

  • RWD11 Real-World Unmet Needs in Patients With HER2-Negative Advanced Gastric, Gastro-Esophageal or Esophageal Adenocarcinoma Receiving First-Line Treatment Globally

    Jul 1, 2025, 00:00

  • RWD120 Comparison of Demographics and Clinical Characteristics Using Real World Data from Tempus Multimodal Database and SEER Cancer Registry Across 17 Solid Cancer Cohorts

    Jul 1, 2025, 00:00

  • EE471 Patient Value Assessment Using a Unified Measure Based on Data Envelopment Analysis: A Case Study

    Jul 1, 2025, 00:00

  • EE233 Cost and Prevalence of Pre-Analytical Errors: A Narrative Review

    Jul 1, 2025, 00:00

  • EPH3 Assessing Prescribing Trends for Select Glucagon-Like Peptide Receptor Agonists (GLP-1s) by Patient Demographics, Providers, and Indication

    Jul 1, 2025, 00:00

  • CO69 Combining Patient Clustering and Quantitative Benefit-Risk Assessment in the Comparison of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention

    Jul 1, 2025, 00:00

  • HPR149 Analysis of 20 Years of Legislative Trends to Predict Future Investment and Access to Orphan Drugs

    Jul 1, 2025, 00:00

  • CO39 Risk of Cutaneous Adverse Drug Reactions with GLP-1 Receptor Agonists: Insights from FAERS and Systematic Review

    Jul 1, 2025, 00:00

  • HSD6 The Impact of One-Day Surgery Performance Indicators on Hospital Capacities in Hungary

    Jul 1, 2025, 00:00

  • EE357 Cost-Effectiveness Analysis of Technosphere Insulin (TI) Versus Insulin Aspart Injection in Type 1 Diabetes Management: Perspective From the US Healthcare System

    Jul 1, 2025, 00:00

  • RWD88 Real World Treatment Patterns, Genetic Testing, and Clinical Outcomes among Patients with mCRPC Treated with Olaparib Monotherapy in US Urology Clinics

    Jul 1, 2025, 00:00

  • P43 IPDvariate: Reconstructing Patient Characteristics and Survival Data from Kaplan-Meier Curves for Subgroup Analysis

    Jul 1, 2025, 00:00

  • HSD7 Development of Hungarian One-Day Surgical Care in the Public-Funded National Healthcare System From 2010 to 2023

    Jul 1, 2025, 00:00

  • RWD54 Characteristics of Adults With Type 2 Diabetes Who Are Not Treated With A Glucose-Lowering Agent: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • PCR3 Changes in Functional Status, Work Productivity, and Daily Activities in People With Idiopathic Hypersomnia and Narcolepsy Treated With Low-Sodium Oxybate: Results From the Phase 4 DUET Study

    Jul 1, 2025, 00:00

  • HPR49 Formulary Inclusion for Oncologic Indications: Comparing FDA-Approved Indications and Off-Label Compendia Support

    Jul 1, 2025, 00:00

  • PCR22 Differences in Demographic and Clinical Profiles Among Patients Adherent Vs. Non-Adherent to Revefenacin Following a COPD-Related Hospitalization

    Jul 1, 2025, 00:00

  • HSD11 Treatment Patterns in the Management of Vitiligo in a Colombian HMO During 2015-2023: A Real-World Data Study

    Jul 1, 2025, 00:00

  • EPH176 Depression Among Rheumatoid Arthritis Patients Using the Medical Expenditure Panel Survey Database

    Jul 1, 2025, 00:00

  • MSR23 Does Our Instrument Include the Right Response Options? Empirical Evidence to Evaluate Floor and Ceiling Effects for Multi-Item Ordinal Instruments

    Jul 1, 2025, 00:00

  • PCR125 Patients' Experiences With Prescription Opioid Use for Acute and/or Chronic Pain Management: A Qualitative Study

    Jul 1, 2025, 00:00

  • PCR246 Preferences for Parkinson's Disease Treatments: A Scoping Literature Review

    Jul 1, 2025, 00:00

  • EE244 Economic Feasibility of 'Pay One Price': An Analysis of Three Biosimilar Molecules with Different Prices and Indicated for Rheumatoid Arthritis in a Medium Size HMO

    Jul 1, 2025, 00:00

  • PCR111 Tracking Patterns in Sleep Disturbances During Flare-Ups in Patients With Atopic Dermatitis: Insights From an App-Based Digital Health Tracking Study

    Jul 1, 2025, 00:00

  • Stakeholder Views on the Use and Challenges of Using Early Economic Evaluations in Health Innovation Development in The Netherlands

    Jul 1, 2025, 00:00

  • EE367 A Framework for Evaluating the Economic and Operational Impact of Adopting the Sentimag®platform for Lesion Localization and Sentinel Lymph Node Biopsy in Women with Breast Cancer

    Jul 1, 2025, 00:00

  • MSR50 Balancing Baseline Characteristics With SMOTE and Propensity Score Weighting in a Comparative Study of PASCAL Transcatheter Valve Repair and Medical Therapy for Degenerative Mitral Regurgitation

    Jul 1, 2025, 00:00

  • PCR1 Health-Related Quality of Life Research in Jordan: A Systematic Review of Published Studies

    Jul 1, 2025, 00:00

  • EPH189 A Retrospective Claims Study Characterizing the Association Between RSV Infection and Acute Otitis Media and Related Burden in Infants and Young Children = 5 years in Japan

    Jul 1, 2025, 00:00

  • MSR22 Evaluating the Application of GPT-4o and Retrieval-Augmented Generation (RAG) for Assessing Risk of Bias and Study Quality in Systematic Literature Reviews (SLRs): Preliminary Findings from a Comparative Study

    Jul 1, 2025, 00:00

  • EE298 Optimized Treatment Sequences for ALK+ Stage IV NSCLC: Cost-Effectiveness Analysis From RCT data and Real-World Evidence

    Jul 1, 2025, 00:00

  • RWD161 The Contribution of Lab Results Data Linked to Claims Data in Identifying Chronic Kidney Disease Staging

    Jul 1, 2025, 00:00

  • EPH140 Analysis of the Epidemiological Burden of Osteoarthritis in Hungary Based on Data From the Global Burden of Disease Study

    Jul 1, 2025, 00:00

  • EPH49 Characteristics and Adherence of Patients Initiating Injectable Cabotegravir for HIV Treatment or Prevention

    Jul 1, 2025, 00:00

  • HPR135 Learnings from State and Federal Drug Pricing Negotiations Across the United States: the Impact of Prescription Drug Affordability Boards

    Jul 1, 2025, 00:00

  • PCR10 Discontinuation Rates of Once-Weekly GLP-1 Receptor Agonists (GLP-1 RAs) in Patients With Type 2 Diabetes

    Jul 1, 2025, 00:00

  • EE492 Association Between Elevations in Alkaline Phosphatase and Healthcare Utilization and Costs Among Individuals With Primary Biliary Cholangitis In The United States

    Jul 1, 2025, 00:00

  • HPR148 Payer Survey Uncovers Likely Increased Management Strategies Following Release of Initial 10 Drugs Selected for Price Negotiation

    Jul 1, 2025, 00:00

  • PCR215 Self-Reported Health-Related Quality-of-Life in Adolescent Patients with Complex Chronic Health Conditions from A Longitudinal Registry Study in Los Angeles County

    Jul 1, 2025, 00:00

  • EPH68 Mortality trends in Centenarians in Colombia, 2008 - 2022

    Jul 1, 2025, 00:00

  • CO64 Discordance Between Apolipoprotein B (apoB) and LDL-Cholesterol (LDL-C) and Incident Hypertension Risk among Patients with and without Type 2 Diabetes (T2D): An Analysis of US Real-World Data

    Jul 1, 2025, 00:00

  • P19 Advancing Equity in CAR T-Cell Therapy: An Analysis of Health Technology Assessments by Canada's Drug Agency and the National Institute for Health and Care Excellence

    Jul 1, 2025, 00:00

  • RWD138 Predictor of dispensing behavior for mental health treatments in Saudi Arabia

    Jul 1, 2025, 00:00

  • MSR133 A Comprehensive Review of Real-World Evidence (RWE) Use in Submissions to Canada's Drug Agency (CDA)

    Jul 1, 2025, 00:00

  • HPR85 The Duration of Medically Necessary Drug Shortages

    Jul 1, 2025, 00:00

  • PCR256 Patient Perspectives on Communication With Clinicians: A Survey on Hospitalized Patient Experiences

    Jul 1, 2025, 00:00

  • EE278 A Systematic Scoping Review of Published Economic Analyses of Public Cord Blood Banking: Is It Time to Re-Assess?

    Jul 1, 2025, 00:00

  • P25 HELMET: A Benchmark Dataset for Evaluating Generative AI in Health Economics and Outcomes Research

    Jul 1, 2025, 00:00

  • EE239 Value of Liquid Biopsy for Genomic Profiling in Non-Small Cell Lung Cancer in Fran A Pharmacoeconomic Model

    Jul 1, 2025, 00:00

  • EE264 Number Needed to Treat and Associated Costs Per Additional Responder of Biologic Therapies in Adult Patients With Moderate To Severe Atopic Dermatitis

    Jul 1, 2025, 00:00

  • HSD109 Hospital-Level Effects on Cardiovascular Monitoring Among Cancer Patients Treated with Cardio-Toxic Therapies

    Jul 1, 2025, 00:00

  • MSR92 The Importance of Specifying the Estimand in Meta-Analyses in the Presence of Treatment Switching

    Jul 1, 2025, 00:00

  • MSR137 A Statistical Method for Quality Assessment of Demographic Variables in EHR Data

    Jul 1, 2025, 00:00

  • EE262 Epidemiological and Economic Analysis of Hospitalizations for Cellulitis and Erysipelas From the Perspective of a Brazilian Health Insurance Company

    Jul 1, 2025, 00:00

  • PCR77 Development of a Conceptual Model of the Patient Experience with Idiopathic Hypersomnia: Patient Interviews from a Clinical Trial (NCT05156047)

    Jul 1, 2025, 00:00

  • HPR24 Moving the Needle: Value and Use of Real-World Evidence in Oncology Clinical Pathways Decision-Making

    Jul 1, 2025, 00:00

  • RWD136 Integration of Survival Analysis Outputs Into Excel-Based Cost-Effectiveness Models Using Generative AI

    Jul 1, 2025, 00:00

  • EE353 Cost-Effectiveness Analysis of Regorafenib Versus FTD-TPI + Bevacizumab in Patients with Metastatic Colorectal Cancer from the Perspective of the Brazilian Supplementary Health System

    Jul 1, 2025, 00:00

  • MSR26 Sentence-Level Abstract Section Classification in HEOR Literature using a Biomedical Language Model

    Jul 1, 2025, 00:00

  • PCR236 Examining The Association Of Self-Reported Condition Severity And Excessive Daytime Sleepiness Severity With Health-Related Outcomes Among Individuals With Narcolepsy In The United States

    Jul 1, 2025, 00:00

  • PCR223 Lifestyle Habits of Patients with Prediabetes Before and After Diagnosis

    Jul 1, 2025, 00:00

  • MSR16 AI-Driven Evidence Synthesis: Leveraging RAG and Multi-Agentic Approach to Conduct Disease Landscape Assessments

    Jul 1, 2025, 00:00

  • P39 Cost-Effectiveness of Transthyretin Stabilizing Agents for the Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

    Jul 1, 2025, 00:00

  • EE214 Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States

    Jul 1, 2025, 00:00

  • PCR212 Development and Psychometric Validation of Patient-Reported Outcome Measures for Masseter Muscle Prominence (MMP): The Lower Facial Shape Questionnaire

    Jul 1, 2025, 00:00

  • HTA93 Moving Beyond Partitioned Survival Models in Oncology Submissions: Incorporation of Canada's Drug Agency Guidance on Model Structure

    Jul 1, 2025, 00:00

  • EE461 Costs And Healthcare Resource Utilization In Patients With Transthyretin Amyloid Cardiomyopathy: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • HSD80 Assessing Real-World Dosing Patterns for Vesicular Monoamine Transporter-2 Inhibitors (VMAT2i), Valbenazine and Deutetrabenazine, Among Patients with Tardive Dyskinesia (TD) in a Nationwide US Claims Database

    Jul 1, 2025, 00:00

  • EPH53 Analysis of the Contribution of Air Pollution and Noise Levels to Predicting Autonomic Nervous System Disorders: An Interpretable Machine Learning Approach

    Jul 1, 2025, 00:00

  • MSR151 Group-Based Trajectory Modeling to Identify Longitudinal Patterns of Adherence to Statins in Older Adults on Concomitant Triple Therapy (Oral Antidiabetic, RAS Antagonists, Statins)

    Jul 1, 2025, 00:00

  • MSR34 Development of a Novel Approach to Improve Binary Classification Prediction Tasks When Encountering Time-To-Event Data: Performance Comparison of Three Alternative Approaches To Predict Stimulant Use Disorder Among Persons Authorized ...

    Jul 1, 2025, 00:00

  • MSR5 Translation, Cross-Cultural Adaptation and Psychometric Evaluation of the Yoruba Version of Musculoskeletal Health Questionnaire

    Jul 1, 2025, 00:00

  • PCR105 The Impact of Caring for Juvenile Idiopathic Arthritis Patients on Caregivers’ Quality of Life

    Jul 1, 2025, 00:00

  • EPH177 Advancing Health Economics: Incorporating AMR Impact Into Pneumococcal Vaccine Assessment

    Jul 1, 2025, 00:00

  • HTA56 A Targeted Review of the Application of Discrete Event Simulation Modeling in CDA-AMC Assessments

    Jul 1, 2025, 00:00

  • MSR105 Stability of a Large Language Model for Data Extraction in Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • EPH55 Comparison of an Innovative Static Model With Dynamic Adjustment With a Dynamic Model To Assess the Public Health Impact of TAK-003 Vaccination: Case Studies in Thailand and Brazil

    Jul 1, 2025, 00:00

  • EE329 Impact of Route of Administration and HCP- or Self-Administration on Pricing of Non-Oncology Orphan Products, 2015-2024

    Jul 1, 2025, 00:00

  • EE422 Integrating Metrics of Environmental Sustainability into Economic Evaluations: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EPH11 Adverse Events Associated With Recently Approved Alzheimer's Drugs: A Real-World Pharmacovigilance Study

    Jul 1, 2025, 00:00

  • HTA45 Analysis of NICE Assessments for Orphan Treatments and Key Drivers for Decision-Making

    Jul 1, 2025, 00:00

  • PCR196 Hypophosphatasia (HPP) Patient Treatment Experien A Mixed Methods Study Concept

    Jul 1, 2025, 00:00

  • MSR132 Association Between Initiation of ENDS and Cigarette Smoking Reduction: A Causal Time Zero Approach to the PATH Study

    Jul 1, 2025, 00:00

  • RWD119 Identification and mapping of Real-World Data Sources for Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)

    Jul 1, 2025, 00:00

  • EE361 Treatment Patterns and Efficacy/Safety of the Drugs in HER2+ NSCLC: A Systemic Literature Review

    Jul 1, 2025, 00:00

  • HSD41 Impact of Racial and Ethnic Disparities on Health-Related Quality of Life in Older Adults With Arthritis in the United States

    Jul 1, 2025, 00:00

  • PCR33 Development of New Patient Reported Outcome (PRO) Conceptual Models for Treatment Adherence and Satisfaction in People with HIV

    Jul 1, 2025, 00:00

  • EE475 Description and Healthcare Resource Utilization of Patients With Moderate or Severe Lupus Using US Insurance Claims

    Jul 1, 2025, 00:00

  • RWD57 Linkage of Clinical Trial Data to Real-World Data (RWD) Sources: A Scoping Review

    Jul 1, 2025, 00:00

  • HPR118 The Role of Invasive Diagnostics in Prior Authorization for MASH

    Jul 1, 2025, 00:00

  • CO32 Socioeconomic Status and Anti-obesity Medications: Impact on Cardiovascular Risk in Medicare Patients with Obesity

    Jul 1, 2025, 00:00

  • PCR39 Patient-Centered Research (Patient-Reported Outcomes and Quality of Life Outcomes)

    Jul 1, 2025, 00:00

  • EPH170 Administrative Frequency of Vitiligo and Clinical Characteristics in a Colombian HMO: A Real World Data Characterization From 2015 to 2023

    Jul 1, 2025, 00:00

  • MT36 Hospital Budget Impact Model of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants

    Jul 1, 2025, 00:00

  • RWD41 Shifting Landscapes: Rising Trends in Breast and Colon Cancer Screenings and Diagnoses

    Jul 1, 2025, 00:00

  • EPH93 Protocol for a Real-World Retrospective Study on Cardiovascular Outcomes in Japan Comparing Heated Tobacco Product Users, Cigarette Smokers, Former Smokers, and Never Smokers

    Jul 1, 2025, 00:00

  • EPH165 Race, Social Determinants of Health (SDoH), and Stage at Breast Cancer Diagnosis in Electronic Health Records (EHR) Data

    Jul 1, 2025, 00:00

  • HPR157 Evaluating the Effect of Type of Insurance Coverage on Changes in Prescription Medication Utilization During the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • HSD81 A Real-World Perspective of Quadruple Treatment Patterns for 1L Multiple Myeloma Patients across North and South America, Europe and Asia

    Jul 1, 2025, 00:00

  • EPH57 Administrative Incidence and Prevalence of Multiple Myeloma Using Administrative Claims Data From a Large Health Maintenance Organization in Colombia, 2015–2023

    Jul 1, 2025, 00:00

  • PCR242 The Economic Burden of Narcolepsy in the United States: Matched Analysis of National Health and Wellness Survey Data

    Jul 1, 2025, 00:00

  • RWD152 Real-World Health-Related Quality of Life and Treatment Satisfaction in Patients With High-Risk Non-Muscle Invasive Bladder Cancer

    Jul 1, 2025, 00:00

  • MSR24 Leveraging Machine Learning to Assess the Association of Rash and Survival in Patients With Advanced NSCLC

    Jul 1, 2025, 00:00

  • MSR106 Breaking Linguistic Barriers: Cross-Language HEOR Evidence Integration Through GenAI

    Jul 1, 2025, 00:00

  • EE423 Treatment Patterns, Clinical Outcomes, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Metastatic Gastric/Gastroesophageal Junction Cancer in Medicare Beneficiaries

    Jul 1, 2025, 00:00

  • MSR142 Performance Assessment and Validation of Real-World Response Data Generated Using a Deep Learning-Based Natural Language Processing Model Across Multiple Solid Tumors

    Jul 1, 2025, 00:00

  • EPH45 Evaluating the National and Regional Prevalence and Incidence Rates of Hepatitis Delta Virus Among Patients With Hepatitis B Virus Infection in Italy

    Jul 1, 2025, 00:00

  • EPH128 Changes in the Prevalence of Pregnancy Complications During the COVID-19 Pandemic: Is Increased Prevalence the New Normal?

    Jul 1, 2025, 00:00

  • EPH46 Evaluation of Epidemiological Disease Burden of Endometriosis Based on Routinely Collected Health Data Between 2010 and 2019

    Jul 1, 2025, 00:00

  • HTA97 Is the Assumption of Treatment Waning Applied Consistently Across Canada’s Drug Agency Reimbursement Reviews? Reviewing Pharmacoeconomic Assessments of Disease Modifying Therapies for the Treatment of Multiple Sclerosis

    Jul 1, 2025, 00:00

  • P38 Cost-Effectiveness of Belimumab for the Treatment of Adults With Active Lupus Nephritis in Canada

    Jul 1, 2025, 00:00

  • OP11 Audience and Publication Profiles in HEOR Research: A Cross-Sectional Analysis of Non-Small-Cell Lung Cancer and Coronary Artery Disease Studies in 2024

    Jul 1, 2025, 00:00

  • EPH169 Contemporary Treatment Patterns of Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Analysis of German Claims Data

    Jul 1, 2025, 00:00

  • EE508 Abnormal Uterine Bleeding in Brazil: Comparison of 52mg LNG-IUS and Histerectomy

    Jul 1, 2025, 00:00

  • MSR123 Standardized Tools for Constructing DAGs - Advancing Causal Inference and Risk Assessment in Pharmaceutical Studies

    Jul 1, 2025, 00:00

  • HSD31 Identification of Barriers to and Practical Strategies for Increasing Clinical Trial Diversity: A Scoping Review

    Jul 1, 2025, 00:00

  • HTA91 Advancing Equitable Access to Cystic Fibrosis Treatment in Brazil: Strategies for Implementing National Clinical Guidelines

    Jul 1, 2025, 00:00

  • RWD116 Training and Validation of CARAaiTM: A Multi LLM Platform and Data Model to Address Oncology-Specific Challenges in Clinical Data Extraction

    Jul 1, 2025, 00:00

  • MSR31 Using Artificial Intelligence to Predict Patient's Preferences

    Jul 1, 2025, 00:00

  • P37 Trial-Based Economic Evaluation of the BrainACT Study: Acceptance and Commitment Therapy for Anxiety and/or Depressive Symptoms After Acquired Brain Injury in the Netherlands

    Jul 1, 2025, 00:00

  • MSR107 MetaSLR in Automating the Data Collection for Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • EE384 Cost Trends of Potentially Inappropriate Medications Among Older Adults between 2012 and 2021 in Quebec, Canada: A Population-Based Repeated Cross-Sectional Study

    Jul 1, 2025, 00:00

  • MSR9 Using Autonomous Generative AI Agents for Data Extraction from Clinical Study Reports: Accuracy Assessment Against Canada's Drug Agency Reports

    Jul 1, 2025, 00:00

  • P20 The Past, Present, and Future of Demand for Bariatric Surgery in Chile: A Subgroup Analysis for no-income (Group A) FONASA Beneficiaries

    Jul 1, 2025, 00:00

  • RWD52 Treatment Patterns for Sleep Disorders in the United States Veterans Affairs Healthcare System

    Jul 1, 2025, 00:00

  • EPH39 Estimating the Prevalence of Chronic Conditions in Population Health Management

    Jul 1, 2025, 00:00

  • HPR55 Assessing the Impact of the United States (US) Inflation Reduction Act (IRA) Regulations on Investment Incentives for Orphan Disease Drug Development

    Jul 1, 2025, 00:00

  • CO10 A Real-World Retrospective Cohort Study Characterizing Patients with MMN in the United States

    Jul 1, 2025, 00:00

  • PT25 The Impact of Financial Assistance Programs on Medication Adheren A Systematic Review With AI-Driven Prediction

    Jul 1, 2025, 00:00

  • PCR2 Landscape Review of Patient Engagement in the Health Technology Assessment (HTA) Process in Latin America

    Jul 1, 2025, 00:00

  • EE484 A Return On Investment Evaluation Of An Antibiotic Audit And Feedback Program Among Family Physicians

    Jul 1, 2025, 00:00

  • HPR12 Exploring the Equity of Out-of-Pocket Healthcare Expenses and Catastrophic Healthcare Expenditures in Taiwanese Households

    Jul 1, 2025, 00:00

  • EE419 Cost-Effectiveness Analysis of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Adults 60 Years of Age and Older in Japan

    Jul 1, 2025, 00:00

  • RWD143 Advancing Breast Cancer Research in Japan Using EHR-Derived Real-World Data

    Jul 1, 2025, 00:00

  • HTA65 An Overview of Pricing and Reimbursement Frameworks for Medicinal Products in Central and Eastern European (CEE) Countries: Mechanisms, Rules, And Managed Entry Agreements (MEAs)

    Jul 1, 2025, 00:00

  • MSR129 Healthcare Resource Utilization Disruptions During the COVID-19 Era and Methodological Considerations: A Review

    Jul 1, 2025, 00:00

  • RWD65 Real-World Treatment Patterns, Patient Characteristics, Healthcare Resource Utilization and Costs for Intermediate Hepatocellular Carcinoma Patients in Canada: A Retrospective Cohort Study Using Provincial Administrative Data

    Jul 1, 2025, 00:00

  • PCR83 Treatment Preferences Related to Long-Acting Injectable Buprenorphine Among Patients With Opioid Use Disorder in Australia, Finland, Germany, and Italy

    Jul 1, 2025, 00:00

  • PCR46 The Association Between COVID-19 Vaccination and Health-Related Quality of Life and Work Productivity: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • MSR57 Extended MAIC to Validate Results in Cases of Poor Population Overlap: An Application to Compare Prophylactic Treatments in Pediatric Patients With Hemophilia A

    Jul 1, 2025, 00:00

  • EPH17 Time to Diagnosis of Lung Cancer From Identification of a Pulmonary Nodule in the United States

    Jul 1, 2025, 00:00

  • MSR156 Examining Factors Contributing to Age of Late-Onset Autoimmune Disease in U.S. Adults Using Hierarchical Clustering Mechanisms

    Jul 1, 2025, 00:00

  • RWD109 Trends in the Global Drug Development Pipeline 2024

    Jul 1, 2025, 00:00

  • EE381 Estimating the U.S. Economic Burden of Autoimmune Diseases: A Pilot Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR185 Associations Between Social Vulnerability and Long COVID: A Nationwide U.S. Study Among Symptomatic Outpatient

    Jul 1, 2025, 00:00

  • EE304 A Cost Minimization and Budget Impact Analysis of an Eculizumab Biosimilar, ABP 959, From the Spanish Healthcare Perspective

    Jul 1, 2025, 00:00

  • CO58 Progression-Free Survival and Objective Response Rates As Surrogate Endpoints for Overall Survival Among Patients With ROS1+ Locally Advanced or Metastatic Non-Small Cell Lung Cancer Receiving ROS1 Tyrosine Kinase Inhibitors

    Jul 1, 2025, 00:00

  • PCR217 How Disease Modifying Therapy Utilization In Multiple Sclerosis Is Influenced by Insurance and Out-Of-Pocket Cost in US Adults: A Summary Of Recent Literature

    Jul 1, 2025, 00:00

  • HTA77 How to Best Model Caregiver Quality of Life in Health Technology Assessments? Lessons from NICE Submissions in Multiple Sclerosis

    Jul 1, 2025, 00:00

  • RWD30 Assessing and Comparing Inpatient Hospitalization Outcomes for COPD in the United States and OECD Countries

    Jul 1, 2025, 00:00

  • EPH146 Pre-Diagnostic Healthcare for People with Fragile X Syndrome

    Jul 1, 2025, 00:00

  • HTA34 Assessability of Single-Arm Studies (SAT) Under Joint Clinical Assessment (JCA): Whether Drugs Assessed With SAT in the Last Years Would Fit Under the New EU HTA Framework?

    Jul 1, 2025, 00:00

  • EE387 Durability and Cost-Minimization of Reprocessed Surgical Drills

    Jul 1, 2025, 00:00

  • RWD135 Retrospective Databases in Health Outcomes, Pharmacoepidemiology, and Pharmacy Practice Research

    Jul 1, 2025, 00:00

  • EPH91 Conceptual Mapping of Health-Related Quality of Life, Quality of Life, and Wellbeing: A Systematic Review and Assessment of Commonly Used Patient Reported Outcomes Measures

    Jul 1, 2025, 00:00

  • RWD31 The Role of Real-World Evidence in Breast Cancer Drug Submissions to NICE: Insights and Challenges

    Jul 1, 2025, 00:00

  • RWD8 Variability in Definitions and Measurement Approaches of Vaso-Occlusive Crises (VOCs) in Sickle Cell Disease (SCD): A Targeted Literature Review of Global Real-World Evidence (RWE) Studies

    Jul 1, 2025, 00:00

  • HSD15 Hypertrophic Scar Severity and Clinical Management in the Real-World Dermatology Setting

    Jul 1, 2025, 00:00

  • PCR160 Real-World Evidence of Setmelanotide in Patients with Rare Melanocortin-4 Receptor Pathway Diseases: Baseline Findings from the RESTORE Longitudinal Survey Study

    Jul 1, 2025, 00:00

  • PCR141 Estimating the HRQoL Shortfall of Long COVID: Meta Analysis of Cohort Studies Relative to Population Norms

    Jul 1, 2025, 00:00

  • HPR77 Analysis of Real-World Evidence Use Across FDA Submissions in 2022 and 2023

    Jul 1, 2025, 00:00

  • EE345 Assessing Health-Related Quality of Life Using the EQ-5D-5L Among Hong Kong Adult Population: The Role of Lifestyle Behaviours

    Jul 1, 2025, 00:00

  • EPH174 Sociodemographic Determinants and Inequities in Prenatal Healthcare in the Canadian Province of Manitoba: A Population-Based Cohort Study 2010-2022

    Jul 1, 2025, 00:00

  • RWD28 Hospitalization for Respiratory Tract Infections Increase the Use of Medical Care and Long-Term Care Services: A Pre-Post Assessment Adopting Difference-in-Differences Analysis on LIFE Study Data

    Jul 1, 2025, 00:00

  • PCR192 From Short-Term Relief to Long-Term Benefits: Tracking the Impact of Insulin Pumps on Fear of Hypoglycemia in people with Type 1 Diabetes Mellitus

    Jul 1, 2025, 00:00

  • HSD64 Real-World Adjuvant Nivolumab Utilization in Surgically Treated Muscle-Invasive Bladder Cancer Patients within U.S. Community Oncology Practice

    Jul 1, 2025, 00:00

  • RWD97 Real-World Treatment Patterns of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patients from the Integra Connect Database

    Jul 1, 2025, 00:00

  • MSR25 NMCP Delayed Time to Hospital Encounter and Reduced Cost compared to OMCP in Patients with Gastroparesis - A Real World Study

    Jul 1, 2025, 00:00

  • HPR41 Are Patients With Major Depressive Disorder (MDD) Getting Access to Innovation in HTA Markets? Review of Reimbursement Decisions of Pharmacotherapies for MDD in Europe, Australia, and Canada From 2001 to 2021

    Jul 1, 2025, 00:00

  • PCR28 Analysis of the Quality of Life of Patients Undergoing Hip Replacement Surgery Using the SF-36 Questionnaire

    Jul 1, 2025, 00:00

  • PT31 Psychometric Testing of the ICECAP-A in Patients With Coeliac Disease: A Comparative Analysis With EQ-5D-5L

    Jul 1, 2025, 00:00

  • P16 The Impact of Hallucinations in Synthetic Health Data on Prognostic Machine Learning Models

    Jul 1, 2025, 00:00

  • MSR154 An Illustration of the Impact of Confounding Bias On Economic Evaluations in the Context of Real-World Evaluations

    Jul 1, 2025, 00:00

  • HPR122 Predicted vs. Actual Drug Spending for Interferon-Free Direct-Acting Antiviral Therapies in Hepatitis C: A Case Study on Drug Spending Forecasts

    Jul 1, 2025, 00:00

  • EPH127 Assessment of Racial Disparities in Prenatal Flu Vaccination in the United States

    Jul 1, 2025, 00:00

  • PCR173 Psychometric Evaluation of the Mastocytosis Symptom Severity Daily Diary (MS2D2) Instrument in Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM)

    Jul 1, 2025, 00:00

  • SA9 Methodological Approaches and Current Applications of Distributed Cost-Effectiveness Analysis: A Systematic Review

    Jul 1, 2025, 00:00

  • MSR60 From AI to Experts: Understanding Pre-Election Inflation Narratives on Social Media via Sentiment and Topic Analysis

    Jul 1, 2025, 00:00

  • MSR20 Discordance Between Two Claims-Based Frailty Indices in a Hospitalized Medicare Population

    Jul 1, 2025, 00:00

  • HTA86 Focus Group Evaluation of Criteria for the Value Assessment of Medication-Adherence Enhancing Interventions (MAEIs)

    Jul 1, 2025, 00:00

  • HPR59 Access Disparities in Maintenance Medication among Patients with Mild Asthma

    Jul 1, 2025, 00:00

  • MSR76 A Flexible Dynamic Transmission Model Framework for Evaluating Tuberculosis Treatments: Methodological Challenges and Applications

    Jul 1, 2025, 00:00

  • RWD20 Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in Poland in Comparison With Efficacy Reported in Clinical Trials

    Jul 1, 2025, 00:00

  • HPR111 Assessing Stakeholder Perceptions of Product Portfolio Value Beyond Financial Benefit: Development of a Survey

    Jul 1, 2025, 00:00

  • RWD76 Real-World Treatment Patterns Among Patients With Scalp Psoriasis in Canada

    Jul 1, 2025, 00:00

  • EE390 Real-World Healthcare Resource Utilization (HCRU) and Economic Burden Among Patients With High-Risk Carcinoma-In-Situ (CIS) Non-Muscle Invasive Bladder Cancer (NMIBC) Using a Large Medicare Dataset

    Jul 1, 2025, 00:00

  • MSR72 Integrating Artificial Intelligence (AI) and Machine Learning (ML) Techniques With Real-World Data (RWD) and Real-World Evidence (RWE) to Inform Precision Medicine: A Scoping Review

    Jul 1, 2025, 00:00

  • EPH90 The Potential Clinical Impact of the Moderna Next-Generation COVID-19 mRNA-1283 Vaccine in United States (US) Adults

    Jul 1, 2025, 00:00

  • PCR235 Quality of Life Assessment of Patients Undergoing Hip Replacement Surgery in the Public and Private Healthcare Systems

    Jul 1, 2025, 00:00

  • EE334 Economic Evaluation of Transient Elastography for Significant Fibrosis Detection in Patients With Diabetes Mellitus in Thailand

    Jul 1, 2025, 00:00

  • PT6 Comparison of Meaningful Score Difference Estimates From Longitudinal Item Response Theory and Anchor-Based Methods

    Jul 1, 2025, 00:00

  • EE456 The Cost of Complications In Graft Repair For Extremity Arterial Trauma: Real-World Evidence From Linked Hospital Chargemaster And Insurance Claims Databases

    Jul 1, 2025, 00:00

  • PCR48 An Overview of the Patient Journey and Treatment Utilization in Patients With Prurigo Nodularis

    Jul 1, 2025, 00:00

  • RWD129 type 2 Inflammation and Exacerbator Profiles in COPD Patients: Real-World Data From a Brazilian Specialized Center

    Jul 1, 2025, 00:00

  • RWD63 Real-World Patient Persistence and Adheren A Comparison Of Long Acting Injectables and Oral Antipsychotics Used For The Treatment Of Schizophrenia in a Canadian Adult population

    Jul 1, 2025, 00:00

  • HSD43 Addressing Neighborhood-Level Opioid Data Gaps: Development of an Interactive Dashboard for Prescription Trends and Buprenorphine Access in California

    Jul 1, 2025, 00:00

  • P44 Predicting Overall Survival (OS) from Time to Recurrence (TTR) Using a Copula-Based Patient-Level Surrogacy Model with Parametric Marginal Survival Distributions: Application to Adjuvant Treatment of Patients with Colon Cancer

    Jul 1, 2025, 00:00

  • EE293 A Comparative Assessment of ICER-Sponsored Versus Pharma-Sponsored Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • HPR159 Problems in the Drug System Related to Household Medicine Classification Criteria: A Gap Analysis for Modernizing the Criteria

    Jul 1, 2025, 00:00

  • EE362 Drug Pricing Differentials Across Therapy Areas in EU4, UK, and US

    Jul 1, 2025, 00:00

  • HSD42 Exploring physicians' Perspectives on the Diagnosis Journey of Rare Diseases in the United States (US): Findings from a Cross Sectional Survey

    Jul 1, 2025, 00:00

  • MSR130 Using Real-World Data and Machine Learning to Identify Patients at Highest Risk for Hospitalization Following Respiratory Syncytial Virus Infection

    Jul 1, 2025, 00:00

  • EE342 Healthcare Utilization and Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Ontario, Canada: An Observational Study

    Jul 1, 2025, 00:00

  • EPH72 Pattern of Opioid Prescriptions Among Patients With Breast, Lung, and Colorectal Cancer Diagnosed With Chronic Non-Malignant Pain

    Jul 1, 2025, 00:00

  • HPR145 Medicare Spending on Orphan Drugs With Single and Multiple Rare Disease Indications

    Jul 1, 2025, 00:00

  • PCR207 The Effect of Public Health Awareness Campaigns on Prostate Cancer-Related Online Information-Seeking Behavior: A Hungarian Experience

    Jul 1, 2025, 00:00

  • PCR175 Are Cancer Trials Aligned With FDA's 2021 Guidance on Patient-Reported Outcomes?

    Jul 1, 2025, 00:00

  • PCR172 Knowledge and Willingness to Self-Sampling About Cervical Cancer Screening in Zala County, Hungary

    Jul 1, 2025, 00:00

  • PCR58 Mapping the HAQ-DI to the EQ-5D-5L and SF-6Dv2 Among Chinese Patients With Gout

    Jul 1, 2025, 00:00

  • EE253 Evaluation of Real-World Total Healthcare Costs Difference Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab in HER2+ Breast Cancer Patients

    Jul 1, 2025, 00:00

  • RWD43 Public Awareness and Perspectives on Respiratory Syncytial Virus Vaccination in Hong Kong: A Comprehensive Population-Based Study

    Jul 1, 2025, 00:00

  • EE444 Economic Analysis of the Use of Polyhexamethylene Biguanide Associated with Betaine (PHMB) Gel Compared to Silver Sulfadiazine in the Treatment of Second-Degree Burns

    Jul 1, 2025, 00:00

  • HPR166 Improving the Healthcare System Through Health Technology Assessment: A Case Study of Nepal

    Jul 1, 2025, 00:00

  • HSD61 Impact of Using Telehealth in Primary Care on Healthcare Resource Utilization, Costs, and Medication Adherence in Diabetic Patients

    Jul 1, 2025, 00:00

  • HPR7 Software as a Medical Devi Current Regulations in North America and Europe

    Jul 1, 2025, 00:00

  • EE268 Cost-Effectiveness Analysis of Mirvetuximab Soravtansine in FRa-Positive Platinum-Resistant Ovarian Cancer in Japan

    Jul 1, 2025, 00:00

  • HPR130 Patient Journey Mapping for Common Illness Care Services at Community Pharmacies

    Jul 1, 2025, 00:00

  • MSR30 Evaluating Generative AI in Replicating Health Economic Models: A Case Study on Ulcerative Colitis

    Jul 1, 2025, 00:00

  • HPR167 Understanding How Formulary Pricing Models Shape Medication Accessibility and Financial Burden for Aging Populations

    Jul 1, 2025, 00:00

  • EE495 Economic Impact of Experiential Negative Symptoms Among Patients Living With Schizophrenia: Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • P13 Leveraging Real-World Data and NLP to Identify At Risk Metabolic Dysfunction Associated Steatohepatitis in the General Population

    Jul 1, 2025, 00:00

  • PCR12 Hemolytic Disease of the Fetus and Newborn (HDFN): A Mixed-Methods Preference Study

    Jul 1, 2025, 00:00

  • HPR151 Comparing the Differences in MentalHealthcare Coverage Between US Public and Private Healthcare Insurers

    Jul 1, 2025, 00:00

  • PCR238 Development of a Conceptual Model Supporting a Clinical Outcome Assessment Strategy for Acquired Angioedema Due to C1 Inhibitor Deficiency

    Jul 1, 2025, 00:00

  • PCR252 Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese Patients with Type 2 Diabetes Mellitus

    Jul 1, 2025, 00:00

  • HSD48 Uncovering the Cost of Red Blood Cell (RBC) and Platelet (PLT) Transfusions in Africa, Asia, Oceania, and the Americas and Exploring Related Implications in a Trial Example

    Jul 1, 2025, 00:00

  • PCR113 One Size Doesn’t Fit All: Learnings from a Pilot Survey Assessing Preferences for Improvement vs Worsening of Healthcare Professionals

    Jul 1, 2025, 00:00

  • EE273 Cost-Effectiveness of Integrating Artificial Intelligence-Based Retinal Photographic Cardiovascular Disease risk Assessment with Diabetic Retinopathy Screening Programmes: A Multi-Country Analysis

    Jul 1, 2025, 00:00

  • EE488 The Economic Benefit of Biosimilars in North America: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • HSD35 Treatment Patterns in the Management of Multiple Myeloma in a Colombian HMO During 2015–2023: A Real-World Data Study

    Jul 1, 2025, 00:00

  • EE401 Return on Investment and Waste Considerations for the Implementation of Rechargeable Batteries in Video Laryngoscopes

    Jul 1, 2025, 00:00

  • CO26 A Systematic Review and Meta-Analysis of da Vinci Robotic-Assisted Surgery vs. Laparoscopic or Open Approaches for Benign Colon Conditions

    Jul 1, 2025, 00:00

  • EPH6 Cost and Use of Medical Devices in Incident Early-Onset Myasthenia Gravis Patients in France

    Jul 1, 2025, 00:00

  • PCR95 State of Inclusion of Patient-Centered Endpoints in Duchenne Muscular Dystrophy (DMD) Clinical Trials

    Jul 1, 2025, 00:00

  • HTA43 Assessing the Added Value of Fixed-Dose Combinations in Non-Communicable Diseases: A Comparative HTA Analysis Across Canada, Scotland, France, and Germany (2014-2024)

    Jul 1, 2025, 00:00

  • EE308 Incidence of Opioid Use Disorder and the Associated Economic Burden Among People Managing Acute Pain With Prescription Opioids in the United States in Commercial, Medicare, and Medicaid Populations

    Jul 1, 2025, 00:00

  • HPR35 Disparities in Testing for Mismatch Repair Genes Among Medicare Beneficiaries with Colon Cancer: A Claims-Based Analysis

    Jul 1, 2025, 00:00

  • RWD141 Impact of Social Determinants of Health on Severe Maternal Morbidity and Pregnancy Outcomes

    Jul 1, 2025, 00:00

  • MSR86 Machine Learning for Predictive Modeling of Hospitalization Risk in Myasthenia Gravis Patients Using the MGFA Global Patient Registry: Addressing Imbalanced Data in Real-World Evidence Scenarios

    Jul 1, 2025, 00:00

  • HPR132 Characterizing Post-Pandemic Social Determinants of Health of the Population Testing for COVID-19 in a Nationwide Network in the United States

    Jul 1, 2025, 00:00

  • PCR42 Measuring Patient- and Carer-Reported Outcomes Following Genome Sequencing for Rare Disease Diagnosis: A Psychometric Assessment of Outcome Measurement Instruments

    Jul 1, 2025, 00:00

  • HSD77 Patient and Diagnostic Delay in Patients With Breast or Colorectal Cancer

    Jul 1, 2025, 00:00

  • EE397 Cost-Effectiveness of a Potential Policy to Ban Alcohol Advertising in Australia: A Modeling Study

    Jul 1, 2025, 00:00

  • CO6 Comparative Efficacy and Safety of Adjunctive CT-152 in Major Depressive Disorder: A Frequentist Network Meta-Analysis

    Jul 1, 2025, 00:00

  • EE388 Computer-Assisted Fluoroscopic Navigation Is Cost Effective Compared To Robotic-Assisted And Manual Surgery In Total Hip Arthroplasty

    Jul 1, 2025, 00:00

  • HSD17 Co-Design of a Discrete Choice Experiment for Revascularization Decisions in Complex Coronary Heart Disease: Importance of Patient Perspectives

    Jul 1, 2025, 00:00

  • P59 Application of Bayesian Meta-Analysis in Synthesizing Health State Utility Values for QALY Estimation in Health Economic Evaluations: A Case Study on Advanced Neuroendocrine Tumors

    Jul 1, 2025, 00:00

  • PCR148 Study of Patient Preferences Regarding a New Class of Antihypertensive Medications: A Discrete Choice Experiment in Ukraine

    Jul 1, 2025, 00:00

  • HTA52 Too Many PICOS for Joint Clinical Assessments (JCA)? How To Adapt The Systematic Literature Reviews for Achieving Desired Outcomes

    Jul 1, 2025, 00:00

  • RWD68 AUVI-Q vs. Other Epinephrine Auto-Injector Prescription Was Associated With Reduced Inpatient Hospitalizations for Anaphylaxis in a US Retrospective Commercial Claims Analysis

    Jul 1, 2025, 00:00

  • HPR71 Evaluating the ICER Special Report in the Context of Medicare Drug Price Negotiations: Implications for Manufacturer Pricing and Evidence Strategies

    Jul 1, 2025, 00:00

  • PCR144 Weight Loss Program (WLP): Clinical and Economic Impact Analysis (CEIA) Preliminary Data From an MCDA Related to the Adherence of Obese Patients' Study in BraziL/LATAM/LMIC

    Jul 1, 2025, 00:00

  • HTA95 Mind The Gap: Delays Between Vaccine Licensure And NITAG Recommendation In The US Versus Europe

    Jul 1, 2025, 00:00

  • EPH133 Targeted Literature Review and Qualitative Synthesis of the Burden of Oral Corticosteroid-Related Adverse Events in Autoimmune Conditions

    Jul 1, 2025, 00:00

  • MSR71 Joint Modeling for Clinical Interpretation of ctDNA Tumor Methylation Dynamics During Longitudinal Monitoring

    Jul 1, 2025, 00:00

  • MT24 Health Equity and Robotic-Assisted Surgery with the da Vinci Surgical Systems: A Literature Review

    Jul 1, 2025, 00:00

  • EE284 Is Every Peripheral Catheter the Same? Economic Burden and Budget Impact of Accidents and Phlebitis in Peripheral Venous Access According to Catheter Material and Safety Device

    Jul 1, 2025, 00:00

  • HSD114 Access and Quality of Usual Source of Care and Racial/Ethnic Disparities in US Adults with Multiple Chronic Conditions

    Jul 1, 2025, 00:00

  • P29 Real-World Treatment Patterns of Advanced Melanoma in the United States

    Jul 1, 2025, 00:00

  • RWD51 Trends in the Uptake of SGLT-2 Inhibitors in Type 2 Diabetes Mellitus With Comorbid Cardiovascular Conditions: A Longitudinal Analysis

    Jul 1, 2025, 00:00

  • PCR114 Mapping Health-Related Quality of Life (HRQoL) Measures to Preference Based Measures in Metastatic Hormone Sensitive Prostate Cancer (mHSPC): A systematic literature review

    Jul 1, 2025, 00:00

  • HSD45 US Physician Characteristics Associated With Real-World Evidence Implementation in Oncology Practice

    Jul 1, 2025, 00:00

  • RWD72 Utilizing NLP to Enhance EHR Data Abstraction Accuracy in Waldenström Macroglobulinemia

    Jul 1, 2025, 00:00

  • EE523 Incremental Annual State Level Cost Of Asthma And Future Projections In The United States

    Jul 1, 2025, 00:00

  • RWD25 Use of Patient Support Program Data for Real-World Evidence Generation: Opportunities and Pitfalls Illustrated in a Case Study Assessing Trastuzumab Deruxtecan Among Patients With Breast Cancer

    Jul 1, 2025, 00:00

  • EE314 Cost-Effectiveness Analysis of HIV Prevention and Treatment Portfolios in US Prison Settings

    Jul 1, 2025, 00:00

  • CO28 Understanding Racial Differences in Emergency Room Visits for Patients with Lupus

    Jul 1, 2025, 00:00

  • PCR181 Patient-Reported Outcomes As Important Predictors of Apremilast Persisten A Pooled Analysis of Real-World Data

    Jul 1, 2025, 00:00

  • RWD62 Productivity Loss And Indirect Costs Of Heart Failure: Analysis Of The Brazilian Social Security System

    Jul 1, 2025, 00:00

  • EE256 Cost-Utility Analysis of Lorlatinib in First-Line Treatment of adult patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (aNSCLC) in Colombia

    Jul 1, 2025, 00:00

  • PCR102 Information-Seeking Behavior of Over-the-Counter Medication From 2012 to 2022 Based Google Trends Data in Hungary

    Jul 1, 2025, 00:00

  • EE396 Cost Per Responder Analysis of Patients With 3 Previous Lines and Lenalidomide Refractory Multiple Myeloma Who Received Cilta-Cel in the Brazilian Private Health System

    Jul 1, 2025, 00:00

  • CO96 Development of a Patient Reported Outcome Measure for GastroIntestinal Recoveryafter Surgery (PRO-diGI)

    Jul 1, 2025, 00:00

  • HPR46 Gender Differences in Use of Cerebrospinal Fluid Biomarker Test and Positron Emission Tomography for Diagnosing Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias in the Real World Setting

    Jul 1, 2025, 00:00

  • HSD4 Aggressive End-of-Life Care among Non-Small Cell Lung Cancer Medicare Patients

    Jul 1, 2025, 00:00

  • HTA24 Long-term Predictions for Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer: 40-year Period Extrapolation

    Jul 1, 2025, 00:00

  • HSD101 Treatment Patterns in the Management of Alopecia Areata in a Colombian HMO During 2015-2023: A Real-World Data Study

    Jul 1, 2025, 00:00

  • SA4 Relationship Between Event-Free Survival (EFS) and Overall Survival (OS) in Newly Diagnosed Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

    Jul 1, 2025, 00:00

  • EPH112 Frequency of Gram-Negative Bacteria at the Military Medical Center in Guatemala

    Jul 1, 2025, 00:00

  • RWD110 Validation of Real-World Pathologic Complete Response in Early Stage Triple Negative Breast Cancer

    Jul 1, 2025, 00:00

  • HTA87 Study on Online Tools of Pharmacoeconomic Model Construction and Value Communication

    Jul 1, 2025, 00:00

  • HTA81 Development of a Novel Value Framework for Evaluating Population Genomic Programs Using A Mixed Methods Approach

    Jul 1, 2025, 00:00

  • HSD83 Identifying Drivers for the Timely Referral of Patients for a Rare Disease Diagnosis: A Cross-Sectional Survey of Physicians in the United States

    Jul 1, 2025, 00:00

  • PCR209 Impact of COVID-19 on Quality of Life and Work Productivity Among Symptomatic US Adults Testing Positive for SARS-CoV-2: Interim Analysis of a Nationwide Longitudinal Study

    Jul 1, 2025, 00:00

  • EE206 Cost-Effectiveness of a Hypothetical Dementia Prevention Treatment for Stroke Survivors

    Jul 1, 2025, 00:00

  • RWD42 Predictive Models and Risk Scoring System Development for Assessing Survival in Uterine Cancer Patients With Type 2 Diabetes Mellitus: A Territory-Wide Cohort Study

    Jul 1, 2025, 00:00

  • HTA49 Practical Application of the ICER-developed Clinical Trial Diversity Rating Tool

    Jul 1, 2025, 00:00

  • CO47 Comparative Effectiveness of Novel vs Established Therapies in Obstructive Hypertrophic Cardiomyopathy (HOCM): Insights From a US Electronic Health Records (EHR) Study

    Jul 1, 2025, 00:00

  • HSD5 Assessment of Willingness and Influencing Factors for COVID-19 Booster Vaccination Among Residents of Hong Kong in the Post-Pandemic Context

    Jul 1, 2025, 00:00

  • PT34 Response Performance of General Chinese Children Aged 6-11 to EQ-5D-Y-3L: A Multicenter Study

    Jul 1, 2025, 00:00

  • HPR164 Pediatric Opioid Prescribing Patterns: Analyzing Trajectories Using Texas PDMP Data in the Context of AAP Guidelines

    Jul 1, 2025, 00:00
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »